Precigen (PGEN) FY2015 results: revenue $174 million, up 141.4% on the year
Precigen, Inc. (PGEN) reported revenue of $174 million for fiscal 2015, the year ended 31 December 2015, up 141.4% on the year before. Net income was -$84 million, and diluted earnings per share $-0.76. The figures are the company's own, from the 10-K it filed with the SEC on 29 February 2016.
Revenue
$174 million
+141.4% on the year
FY2011FY2015
Operating margin
-84.6%
-97.3% a year earlier
FY2011FY2015
Net income
-$84 million
FY2011FY2015
Diluted EPS
-$0.76
FY2011FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
174
71.9
23.8
+141.4%
Cost of revenue
63.9
19.3
0.0
+231.9%
Gross profit
110
52.7
23.7
+108.2%
Gross margin
63.2%
73.2%
99.9%
Research and development
147
59.0
48.2
+150.0%
Selling, general and administrative
109
63.6
33.6
+71.3%
Operating income
-147
-70.0
-58.0
Operating margin
-84.6%
-97.3%
-244.2%
Interest expense
1.2
0.7
0.1
+86.8%
Pre-tax income
-87.0
-85.7
-40.9
Income tax
1.0
-0.1
0.0
Net income
-84.5
-81.8
-39.0
Net margin
-48.7%
-113.8%
-164.1%
Diluted EPS
-$0.76
-$0.83
-$1.40
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
35.7
-19.9
-53.7
Capital expenditure
12.7
6.4
1.5
+100.1%
Free cash flow
22.9
-26.2
-55.2
Free cash flow margin
13.2%
-36.5%
-232.4%
Cash from investing
-259
-26.0
-224
Cash from financing
332
24.0
316
+1,281.8%
Depreciation and amortisation
17.7
10.4
7.2
+70.4%
Share-based compensation
38.7
21.8
2.9
+77.0%
Shares outstanding at period end
117m
101m
97m
+16.0%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
694
385
367
+80.4%
Non-controlling interest
10.8
24.5
14.6
-55.9%
Debt
8.5
12.6
1.7
-32.5%
Other liabilities
269
154
86.5
+74.1%
Total liabilities and equity
982
576
469
+70.4%
Fixed assets
42.7
38.0
16.6
+12.5%
Goodwill
165
101
13.8
+63.4%
Intangible assets
248
65.9
42.0
+275.4%
Investments
208
116
189
+79.9%
Cash and equivalents
136
27.5
49.5
+394.4%
Receivables
25.1
14.6
0.8
+72.1%
Other assets
158
214
158
-26.2%
Total assets
982
576
469
+70.4%
10-K for the year ended 31 December 2015, filed 29 February 2016: the filing.